Sandbox 127: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 50: Line 50:
residues in PBP2a; specifically  
residues in PBP2a; specifically  
<scene name='37/372724/Medicine_interaction/2'>Tyr446 and Met641</scene>.The
<scene name='37/372724/Medicine_interaction/2'>Tyr446 and Met641</scene>.The
<scene name='37/372724/Medicine_interaction/1'> medicine</scene> shown as colors of the atom types ([[CPK]]) is able to more efficiently react with the serine active site residue and therefore inhibit the activity of pbp2a as a result of ceftobiprole <scene name='37/372724/R2_interaction/6'>tighter binding</scene> to pbp2a. Unlike penicillin, this results in inhibition of PBP2a.
<scene name='37/372724/Medicine_interaction/1'> medicine</scene> shown as colors of the atom types ([[CPK]]) is able to more efficiently react with <scene name='37/372724/R2_interaction/9'>Ser403</scene> and therefore inhibit the activity of pbp2a as a result of ceftobiprole <scene name='37/372724/R2_interaction/8'>tighter binding</scene> to pbp2a. Unlike penicillin, this results in inhibition of PBP2a.
 
 
<scene name='37/372724/R2_interaction/9'>Ser403</scene>